Pacemaker lead-associated thrombus in JAK2-positive patient

被引:1
|
作者
Peter, Laura Barbara [1 ]
机构
[1] CHU UCL Namur, Site Godinne, Yvoir, Belgium
关键词
D O I
10.1080/00015385.2023.2262856
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:84 / 84
页数:1
相关论文
共 50 条
  • [31] Cerebellar Ataxia With Neuropathy and Bilateral Vestibular Areflexia Syndrome Coexisting With JAK2-Positive Polycythemia Vera and Myelofibrosis
    Saibaba, Jayaram
    Selvaraj, Jayachandran
    Viswanathan, Stalin
    Pillai, Vivekanandan
    OCHSNER JOURNAL, 2025,
  • [32] MK-0457 is a novel aurora kinase and janus kinase 2 (JAK2) inhibitor with activity in transformed JAK2-Positive myeloproliferative disease (MPD).
    Giles, Francis
    Bergstrom, Donald A.
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Andreeff, Michael
    Kantarjan, Hagop
    Jones, Dan
    Freedman, Steven J.
    Verstovsek, Srdan
    BLOOD, 2006, 108 (11) : 309B - 310B
  • [33] Assessing the Feasibility of Thromboprophylaxis with Apixaban in JAK2-Positive Myeloproliferative Neoplasm Patients: The Airport-MPN Trial
    Kimpton, Miriam
    Cerquozzi, Sonia
    Toupin, Dominique
    Villeneuve, Pierre
    Siegal, Deborah
    Carrier, Marc
    Delluc, Aurelien
    BLOOD, 2023, 142
  • [34] A Rare Coexistence of Smoldering Multiple Myeloma and JAK2-Positive Myeloproliferative Neoplasm: A Case of Dual Synchronous Hematological Malignancy
    Hammani, Adnane
    Doghmi, Othman
    Allaoui, Mohammed
    Ababou, Mounir
    Mahtat, El Mehdi
    El Maaroufi, Hicham
    Doghmi, Kamal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [35] Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the Literature
    Bader, Gilbert
    Dreiling, Bernard
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2019, 7
  • [36] JAK2-positive cutaneous myelofibrosis presenting as sclerosing extramedullary hematopoietic tumors on the scalp: case presentation and review of the literature
    LeBlanc, Robert E.
    Lester, Laura
    Kwong, Bernice
    Rieger, Kerri E.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2015, 42 (11) : 858 - 862
  • [37] MK-0457 is a novel aurora kinaseand janus kinase 2 inhibitor with activity in transformed JAK2-positive myeloproliferative disease
    Giles, J.
    Bergstrom, V. D. A.
    Garcia-Manero, G.
    Kornblau, S.
    Andreeff, M.
    Jones, D.
    Freedman, S. J.
    Verstovsek, S.
    Kantarjian, H.
    Rizzieri, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 243 - 244
  • [38] PACEMAKER LEAD FRACTURE ASSOCIATED WITH WEIGHTLIFTING - A REPORT OF 2 CASES
    DEERING, JA
    PEDERSON, DN
    MILITARY MEDICINE, 1993, 158 (12) : 833 - 834
  • [39] Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib
    Paciaroni, Katia
    Campagna, Selenia
    Villiva, Nicoletta
    Maffini, Enrico
    Celesti, Francesca
    Tordi, Attilio
    Lombardi, Mariangela
    Dragonetti, Giulia
    di Toritto, Tommaso Caravita
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2025, 17 (01)
  • [40] Local infection associated with a nonfunctional lead in a patient with a VVI pacemaker: beyond the standard of care
    Zabek, Andrzej
    Boczar, Krzysztof
    Matusik, Pawel T.
    Ulman, Mateusz
    Lelakowski, Jacek
    Malecka, Barbara
    KARDIOLOGIA POLSKA, 2020, 78 (01) : 78 - 79